MX2009007660A - Formulaciones de ciclodextrina. - Google Patents

Formulaciones de ciclodextrina.

Info

Publication number
MX2009007660A
MX2009007660A MX2009007660A MX2009007660A MX2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A MX 2009007660 A MX2009007660 A MX 2009007660A
Authority
MX
Mexico
Prior art keywords
formulations
nose
gels
cyclodextrin formulations
cyclodextrins
Prior art date
Application number
MX2009007660A
Other languages
English (en)
Inventor
Peter Vitins
Marcel Langenauer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of MX2009007660A publication Critical patent/MX2009007660A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención está dirigida a varias formulaciones que comprenden una o más ciclodextrinas, dichas formulaciones siendo particularmente útiles para tratar o prevenir infecciones virales. En formas de realización específicas, las formulaciones comprenden geles de base no acuosa, spray para garganta y nariz, geles nasales, bálsamos labiales y emulsiones.
MX2009007660A 2007-01-17 2008-01-17 Formulaciones de ciclodextrina. MX2009007660A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88529307P 2007-01-17 2007-01-17
PCT/EP2008/000351 WO2008087034A2 (en) 2007-01-17 2008-01-17 Cyclodextrin formulations

Publications (1)

Publication Number Publication Date
MX2009007660A true MX2009007660A (es) 2009-11-18

Family

ID=39563399

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007660A MX2009007660A (es) 2007-01-17 2008-01-17 Formulaciones de ciclodextrina.

Country Status (13)

Country Link
US (1) US20100111883A1 (es)
EP (1) EP2121027A2 (es)
JP (1) JP2010516646A (es)
KR (1) KR20090111328A (es)
CN (1) CN101631565A (es)
AU (1) AU2008207104A1 (es)
BR (1) BRPI0806633A2 (es)
CA (1) CA2675190A1 (es)
IL (1) IL199812A0 (es)
MX (1) MX2009007660A (es)
RU (1) RU2009127890A (es)
SG (1) SG177217A1 (es)
WO (1) WO2008087034A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
JP5858994B2 (ja) 2010-07-08 2016-02-10 デヴィレックス アーゲー 口唇ヘルペス、性器ヘルペス、および帯状疱疹の再発を抑制するためのポリエチレングリコール組成物
EP2618810B1 (en) * 2010-09-21 2016-11-23 S & V Technologies GmbH Cosmetic composition
WO2012174555A2 (en) * 2011-06-16 2012-12-20 Nayan Patel Composition and method for stabilization and delivery of therapeutic molecules
US10328152B2 (en) 2011-06-16 2019-06-25 Nayan Patel Method for stabilization and delivery of therapeutic molecules
CA2856696C (en) 2011-11-23 2020-07-14 3B Pharmaceuticals, Inc. Antiviral formulations for herpes viral infections
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
ES2899756T3 (es) 2013-03-12 2022-03-14 Primal Therapies Inc Composición dental que comprende quelante y base
DE102013021019B4 (de) * 2013-11-29 2016-04-14 Lutz Heuer Feste Massen, bestehend aus beta-Cyclodextrin und Polyethylenglykol, deren Mischungen mit Polyethylenglykolen, Verfahren zur Herstellung von Formkörpern und Verwendungen
EP3037082A1 (en) * 2014-12-22 2016-06-29 Spirig Pharma AG Sprayable cosmetic sunscreen composition
CN109562125A (zh) * 2016-07-22 2019-04-02 洛桑联邦理工学院 杀病毒化合物及其用途
CN115920084A (zh) * 2023-02-17 2023-04-07 武汉科技大学 一种羟甲香豆素环糊精包合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
ES2239369T3 (es) * 1993-03-26 2005-09-16 Franciscus Wilhelmus Henricus Maria Merkus Composiciones farmaceuticas para administracion intranasal de dihidroergotamina.
JP3648330B2 (ja) * 1995-06-29 2005-05-18 株式会社資生堂 化粧料の製造方法、及び口紅用組成物の製造方法
KR100453448B1 (ko) * 1995-06-29 2005-01-13 가부시키가이샤 시세이도 콜레스테롤에스테르포접물,보수조성물,포수조성물,이들을배합한화장료및이들의제조방법
US6596263B1 (en) * 1995-07-14 2003-07-22 Stc English Ideas, Inc. Cyclodextrin compositions
EP0803243B1 (en) * 1996-04-24 2003-03-19 Pfizer Inc. Cyclodextrins and phenolic compounds in dental products
DE19627498A1 (de) * 1996-07-08 1998-01-15 Nat Starch Chem Invest Stärkehaltige Reinigungs- und Pflegemittel
MXPA03004241A (es) * 2000-11-15 2004-12-03 Chandavarkar Mohan A Preparaciones farmaceuticas que comprenden corticosteroides y agentes antiinfecciosos.
US20030044356A1 (en) * 2001-04-20 2003-03-06 Jin Auh Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one)
CA2446060A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
WO2002094324A1 (en) * 2001-05-18 2002-11-28 Institute Of Materials Research & Engineering Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
WO2003080080A1 (en) * 2002-03-21 2003-10-02 Regents Of The University Of Minnesota Cyclodextrin compositions and methods of treating viral infections
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
DE10253042A1 (de) * 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
US20060024247A1 (en) * 2004-07-28 2006-02-02 Bioactives, Llc Oral care formulations comprising highly bioavailable Coenzyme Q-10 cyclodextrin complex
JP2006328039A (ja) * 2005-04-26 2006-12-07 Nippo Kagaku Kk 鳥インフルエンザウイルス不活化剤

Also Published As

Publication number Publication date
BRPI0806633A2 (pt) 2011-09-06
US20100111883A1 (en) 2010-05-06
CA2675190A1 (en) 2008-07-24
WO2008087034A2 (en) 2008-07-24
JP2010516646A (ja) 2010-05-20
SG177217A1 (en) 2012-01-30
WO2008087034A3 (en) 2009-01-29
AU2008207104A1 (en) 2008-07-24
IL199812A0 (en) 2010-04-15
EP2121027A2 (en) 2009-11-25
KR20090111328A (ko) 2009-10-26
RU2009127890A (ru) 2011-02-27
CN101631565A (zh) 2010-01-20

Similar Documents

Publication Publication Date Title
MX2009007660A (es) Formulaciones de ciclodextrina.
ATE481984T1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
EA201890315A1 (ru) Молекулы антител, связывающие cd22
TN2009000398A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds
MX2018000147A (es) Moleculas de anticuerpo que se unen al grupo de diferenciacion 45 (cd45).
DK2190473T3 (da) Peptid med reduceret dimerdannelse
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
CO6280406A2 (es) Polipeptidos anti-microbianos para uso en el tratamiento de transtornos microbianos
BR112012016749A2 (pt) "d-aminoácido para uso no tratamento de biofilmes"
JO2795B1 (en) Immunoglobulins
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201071248A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
WO2008073982A3 (en) 5,6-dihydro-1h-pyridin-2-one compounds
WO2008150530A3 (en) Cripto binding molecules
TN2010000074A1 (en) Cyclic depsipeptides
MY161473A (en) Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
MX2012001306A (es) Inhibicion de matastasis de tumor.
CR11126A (es) Inhibicion de metastasis de tumor por anticuerpos anti neuropilina 2
DK1838716T3 (da) Olanzapinpamota-dihydrat
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
WO2009137900A3 (en) Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust